This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
mmu-miR-2137MIMAT0011213 0.0e+0 2.7e-2microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 3.2e-2microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 3.2e-2microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 4.5e-2 2.0e-1Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 2.9e-2 3.3e-1Profiling circulating microRNA expression in experimental sepsis using cecal ligation and puncture.
PLoS One. 2013 Oct 30;8(10):e77936. doi: 10.1371/journal.pone.0077936. eCollection 2013.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 8.4e-8Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 7.9e-9Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 1.6e-4Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 2.0e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 1.1e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 1.9e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 2.1e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 3.2e-2Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 9.4e-2Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 4.8e-2Influence of Erythropoietin on Microvesicles Derived from Mesenchymal Stem cells protecting renal function of Chronic Kidney disease.
Stem Cell Res Ther. 2015 May 22;6(1):100.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 4.1e-3Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 0.0e+0Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 6.7e-16Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
Not available19 / 0 / 19
mmu-miR-2137MIMAT0011213 0.0e+0 2.6e-8Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.
Not available19 / 0 / 19
[1]